EDGAR Filing Documents for 0001564590-16-023139

Form 8-K - Current report:

SEC Accession No. 0001564590-16-023139

Filing Date

2016-08-08

Accepted

2016-08-08 08:00:17

Documents

Period of Report

2016-08-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	fate-8k_20160806.htm	8-K	36064
2	EX-10.1	fate-ex101_9.htm	EX-10.1	306603
3	EX-10.2	fate-ex102_8.htm	EX-10.2	159674
4	EX-99.1	fate-ex991_70.htm	EX-99.1	10283
5	GRAPHIC	gosyajtsf4v0000001.jpg	GRAPHIC	3811
	Complete submission text file	0001564590-16-023139.txt		519274

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121

Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803

FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 161812760
SIC: 2836 Biological Products, (No Diagnostic Substances)